Surgical Antisepsis



Surgical Antisepsis


Gerald McDonnell



Surgical antisepsis is the application of microbicidal or microbistatic antimicrobial chemicals to skin, mucosa, and wounds to reduce the risk of infection. Antimicrobials have been used, at least since Pharaonic times, in the form of natural products or chemicals to care for wounds and to prevent miasma or contagia causing putrefaction and death.1 Ignaz Semmelweis2 and Joseph Lister3 are considered the fathers of modern antisepsis because of their development of the early principles of antiseptic technique before the new science of bacteriology had evolved. Semmelweis,2 in his treatise on childbed fever, observed a significantly higher rate of postpartum infections among women whose childbirth was managed by physicians compared with those managed by midwives. He recognized the relationship between puerperal infections and physicians’ frequent practice of performing autopsies prior to providing obstetric care and childbirth. Following the implementation of simple hand washing, he demonstrated a decrease in the infection rate from 9.9% to approximately 2%. In 1867, Joseph Lister3 published a technique of surgical preparation with carboxylic acid spray applied to the patient’s skin, all instruments, and gauze, which also led to a dramatic decrease in the postoperative infection rate. Subsequently, the early bacteriologists, beginning with Robert Koch, studied the bacteria of the skin, suggested the possible contribution of these bacteria to the infection of wounds, and studied their reduction or elimination with antimicrobial agents. Price,4 in his classic study of 1938, first proposed that skin bacteria could be considered as two sorts: transients and residents. He demonstrated the effect of hand washing and surgical scrubbing on the removal of skin flora and first showed that viable skin cannot be truly sterilized. Skin flora was studied by many investigators using various techniques as well as more detailed analysis on the various microbiomes that can exist on healthy and compromised skin.5,6,7,8,9,10,11,12

The major premise of surgical antisepsis is the removal or reduction of normal flora by the topical application of antimicrobial substances to the skin before a surgical procedure. With preoperative scrubbing and patient skin preparation, one hopes to reduce both transient and resident flora to the greatest extent and to maintain this state for the duration of the surgical procedure. Despite confident statements that skin disinfection can be achieved, considerable numbers of resident bacteria are found to survive antiseptic treatment in the deeper layers of the skin.13 Early studies suggested that despite best attempts using widely accepted antiseptic agents, the number of skin bacteria cannot be lowered below a certain level.14


SKIN AND SKIN FLORA

It is well established that skin flora plays an essential role in the development of wound infection.7,10,15,16,17 Because an important function of the skin is to serve as a barrier against infection, antiseptic treatment should not be toxic or damaging to the skin,18 cause skin reactions,19,20 or interfere with the normal protective function of the skin.16,17 Indirect effects such as removal of skin lipids, interference with the “acid mantle,” and excessive drying may result in damage to skin, especially in frequent users of antiseptics such as surgeons and nurses.16 As assessed by using objective physiologic parameters by Larson et al,21,23 frequent hand washing can cause some damage to the stratum corneum. Such physiologic studies are needed for all antiseptics in addition to assessing efficacy, toxicity, absorption, and inactivation.24,25,26

The skin is a multilayered surface with irregular pits, ridges, and creases covered by cornified epithelial cells that are loosely attached to the deeper cell layers; thus, the skin provides a nesting place for bacterial flora and is also a potential source of airborne particles carrying microorganisms.27 The surface is interrupted by the openings of sweat glands and pilosebaceous units. Because sweat is essentially sterile, slightly acidic, and flows continually,
it keeps the sweat ducts clean of bacteria. In contrast, the ducts of sebaceous glands contain fatty and proteinaceous materials as well as cells, cell detritus, and salts that can serve as nutrients for a number of organisms composing the resident flora. The fat covers the epidermal surface and makes it water repellent. Its composition changes with age and thereby affects the type and quantity of normal flora. Normal flora also differs on various parts of the body surface, depending on the distribution of the skin secretory glands and their activity; the type, size, and density of hair; bacterial adherence; and antimicrobial antagonism.6,7,8,9 In addition, certain regions of the body, such as the groin and the paragenital area of women, have extremely high bacterial counts (up to 107 colony-forming units [CFUs]/mL stripping solution).28 Others confirmed Price’s work from 1938 that the resident flora is concentrated mainly around and under fingernails.4,29 Unfortunately, whereas it has been established that the subungual space is a significant reservoir of bacteria,30 the routine surgical scrub is often ineffective at reducing the subungual counts to acceptable levels.31 Recognizing the subungual space as a good indicator of the efficacy of personnel hand washes and surgical scrubs, new methods were developed for testing antiseptics by assessing the fluid obtained from artificially contaminated hands after scrubbing the subungual space.32

Many of these earlier studies have been verified in the detailed, molecular analysis of the microbiome on various parts of the skin and the role of resident and transient bacteria as part of a healthy population in comparison to a diseased or unhealthy skin state.33,34 These studies have verified that the microbial population can highly diverse and variable depending on the person, regional anatomy, environmental factors, and various host factors (eg, immune system, personal hygiene, and genetic factors). The range of microorganisms present is now known to be wider than first observed in traditional microbiological culture methods.7,8,9 The most commonly isolated bacteria included gram-positive, coagulase-negative staphylococci (eg, Staphylococcus epidermidis), Micrococcus, and Actinobacteria (eg, Corynebacterium and Propionibacterium species). Modern molecular techniques allow for the identification of a wider range of bacteria. Skin and mucous membrane bacteria are found to be in four major phyla: Actinobacteria (gram-positive bacteria such as Propionibacterium), Firmicutes (gram-positive bacteria such as Staphylococcus, Bacillus, and Clostridium), Bacteroidetes (gram-negative bacteria such as Bacteroides), and Proteobacteria (gram-negative bacteria such as Escherichia coli and Pseudomonas). The proportions of each of these can vary depending on the area of the skin or mucous membranes. For example, areas with increased moisture can lead to greater proportions of bacteria that grow well under humid conditions, such as gram-negative rods and Staphylococcus aureus, and areas with increased presence of sebaceous glands (eg, the face) see a greater proportion of lipophilic bacteria (eg, Propionibacterium) due to the production of sebum in these areas. In addition to bacteria, other members of the skin flora can include a wide range of resident and transient microorganisms such as fungi, arthropods, and viruses. Of particular note are Malassezia species of fungi and Demodex arthropods (mites) are often considered as resident skin flora.33,34

Despite the differentiation of transient and resident flora, both types of flora play important roles in the development of health care-acquired infection (HAI). Many transient bacteria are loosely attached to the lipoidal components of the skin and are generally considered easy to remove using mechanical means. Resident flora, on the other hand, is much more difficult to completely remove and are relatively stable in terms of the density and types of organisms; however, the simple historical notion that transient bacteria are bad and resident flora are harmless can no longer be supported. Researchers demonstrated during the S aureus epidemic in the 1950s and 1960s that this pathogen may become part of the resident flora and may even be disbursed in large quantities by shedders.24 Gram-negative bacteria also may lodge persistently, especially in damaged or moist skin.35 Gram-negative bacteria recovered from nurses’ hands after five consecutive hand washings with nonmedicated bar soap and tap water suggests that these organisms, found independently of patient contact, should be considered nontransient (or transitional) flora.36 Regarding skin carriage of gram-negative bacteria, especially in the axilla, groin, and toe webs, it has been emphasized that each patient may carry his or her own environment.9,10 In addition, the skin flora of personnel from different hospital services (eg, dermatology and oncology) can differ in both its composition and its antimicrobial susceptibility.37 Dermatology personnel showed S aureus more frequently, whereas oncology personnel had a significantly higher carriage of gram-negative bacteria, yeast, and multiple antibiotic-resistant Corynebacterium. The isolates from nurses were found to be generally more resistant to many antibiotics, and two-thirds of the oncology nurses had methicillin-resistant staphylococci. These results support more recent studies with skin flora, where the microbial flora can vary depending on environmental factors (such as working locations). Furthermore, it should be reemphasized that there is wide variation in log differences in the density of bacteria across various sites of the body, with relatively low counts on the palm and much higher counts at other sites, such as the axilla and forehead.6,7,8,9,10


MUCOSA AND WOUNDS

Whereas antisepsis can be more or less successful on unbroken skin, its use on exposed or visceral mucosa, open wounds, and burns is more problematic. Side effects that result from increased absorption of the antimicrobial chemical by the tissue and by the reduction of its activity
by blood, exudates, and tissue result in less efficacious antiseptic regimens. Prevention of surgical infection and therapy of local infection are still considered achievable more effectively with systemic antibiotics.15,38 Although there are many agents that can be specifically applied to wound and burn injuries to decrease infection, it should be emphasized that the primary therapy for prevention of infection in these settings is early mechanical or surgical debridement in association with early skin grafting of burn injuries. Antimicrobial agents, including antiseptics and antibiotics, should only be used in accordance with manufacturers’ label claims, and these can vary regionally. But despite the emphasis on the appropriate use of prophylactic antibiotics to reduce the risk of surgical site infections (SSIs), the parallel use of different antiseptics is recommended to include preoperative bathing (with antimicrobial soaps or antiseptic agents), use of 2% mupirocin ointment in the nares (for decolonization of methicillin-resistant S aureus [MRSA] carriers), surgical site preparation (with an emphasis on the use of alcohols or alcohol/chlorhexidine combinations), surgical hand preparation (uses of antimicrobial soaps or alcohol hand rubs prior to glove donning), and triclosan-containing sutures.15,38


SURGEONS AND ANTISEPSIS

Since Lister’s3 work, surgeons have been aware that wound infections can be prevented by the topical use of antimicrobial chemicals. Because bacteriologists could demonstrate that bacteria on the skin of surgeons or patients could cause wound infections, hand washing and preoperative surgical scrubbing became part of the system of aseptic surgery introduced since 1882 by Trendelenburg, von Bergmann, and Schimmelbusch in Germany and by Halsted in the United States. Antisepsis and asepsis contributed to the rapid development of surgery, and the advent of antibiotics promised further expansion of the surgical horizons. Despite these advances, the rates of SSIs remain a concern and vary internationally. The SSIs are defined as infections of the incision or organ or space that occur after surgery15 and usually occurring within 30 days of an operative procedure.38 They can be further subdivided into infections that are limited to the skin and subcutaneous tissue at the site of incision (superficial incisional), including deep soft tissue (eg, muscle and fascia) at the surgical site (deep incisional), and/or any other part of the anatomy that was accessed during the procedure (organ or space SSIs). The SSIs can also be associated with infections that are associated with deep incisional or organ/space infections that occur within 1 year if implant is left in place. The surgical wound can also be classified into four major types that are also associated with increased infection risk due to the level of damage associated at the wound and other factors (Table 43.1).38 The SSIs remain one of the most common HAIs, estimated to comprise 31% of all infections among hospitalized patients. Between 2006 and 2009, SSIs complicated an estimated 1.9% of surgical procedures in the United States. The Centers for Disease Control and Prevention (CDC) HAI prevalence survey found there were an estimated 157 500 SSIs associated with inpatient surgeries in 2011.15 The SSIs alone can cause serious injury or death at significant cost to patients, families, and health care organizations. A systematic review of the literature on SSI from 1998 to 2014 found the estimated average cost of an SSI ranged between $10 433 and $25 546, which equates to approximately $13 300 to $35 400 in 2019 costs.15,44 In addition, infection remains a further limiting factor of surgical success in certain patients (eg, the obese, diabetics, trauma patients). But, as highlighted earlier,
infections cannot always be controlled by antibiotics alone and are becoming a greater risk with the continuing development of antibiotic-resistant gram-positive (eg, MRSA, vancomycin-resistant Enterococcus [VRE], and various types of mycobacteria) and gram-negative (eg, carbapenem-resistant Enterobacteriaceae) bacteria. Fortunately, the surgical community has retained antisepsis and various usages of biocides as an important component of surgical technique as well as continuing to identify alternatives to antibiotic dependence.15,38,45 Guidelines for the prevention of surgical wound infections in the United States15 and internationally38 address the continuing need for appropriate surgical antisepsis.








TABLE 43.1 Surgical wound classification

























Class


Wound Infection Ratea


Definition


Class I/clean


0.2%-2.9%


An operative wound in which infection or inflammation is not encountered; aseptic technique is maintained; and the respiratory, gastrointestinal, genital, or urinary tract is not entered


Class II/cleancontaminated


0.9%-3.9%


An operative wound in which the respiratory, gastrointestinal, biliary, genital, or urinary tracts is entered under controlled conditions without unusual contamination or when a minor break in aseptic technique occurs


Class III/contaminated


1.3%-8.5%


Open, fresh, accidental wounds. In addition, operations with major breaks in sterile technique or gross spillage from the gastrointestinal tract and incisions in which acute, nonpurulent inflammation are encountered


Class IV/dirty


2.1%-48%


Old wounds with devitalized tissue and those that involve existing clinical infection or perforated viscera


a Rates are estimated and can vary depending on the reports in the literature. (Based on Berríos-Torres et al,15 World Health Organization,38 Reichman and Greenberg,39 Onyekwelu et al,40 Ortega et al,41 Rosenthal et al,42 and Cruse.43)


Staff selecting an antiseptic must be familiar with the spectrum of activity and limitations, appropriate use, potential side effects, risk of failures, potential contamination, cost-effectiveness, and, last but not least, the art to motivate people to use these agents correctly.17,46,47,48,49 An initial recommendation of the CDC50 that hand washing with plain soap suffices for routine use in hospitals was accepted but with some reservations. The data in laboratory and clinical studies could often be variable, depending on the product formulation, test methods used, and comparisons to controls. The overall evidence of the benefit of antimicrobial soaps in many settings continues to be of some debate. For example, the US Food and Drug Administration (FDA) issued a final ruling in 2016 that over-the-counter (OTC) consumer antiseptic wash products containing certain active ingredients (eg, triclosan and triclocarban) can no longer be marketed due to safety and effectiveness concerns in comparison to regular soap and water but at that time deferred ruling on other biocides such as benzalkonium chloride and chloroxylenol (PCMX).51 Similarly, for health care antiseptics, such as health care personnel hand washes, health care personnel hand rubs, surgical hand scrubs, surgical hand rubs, and patient antiseptic skin preparations, a range of biocides (particularly including triclosan) could no longer be generally recognized as safe for health care antiseptic use. In addition, they deferred ruling on a further six types of widely used biocides in antiseptic use (benzalkonium chloride, benzethonium chloride, chloroxylenol, alcohol, isopropyl alcohol, and povidone-iodine). Some widely used biocides such as chlorhexidine have a unique situation as they are currently ineligible for evaluation under the FDA’s OTC drug review for use as a health care antiseptic and therefore continue to require approval under a new drug application to the FDA prior to marketing.

But overall, the use of antiseptics (or skin/hand disinfectants) in health care environments continues to be supported by consensus and evidence-based guidelines internationally.15,17,38,52 But the recommendations have changed depending on the evidence, such as with the emphasis on the use of alcohol-based antiseptics (hand rubs) over antimicrobial soaps (hand washes) than in the past (particularly in the United States, where initial use of various hand rubs was initially low in comparison to other areas such as in Europe; see chapters 19 and 42). These guidelines provide a detailed review of the evidence to support these recommendations and in summary include



  • For general health care hand hygiene, hand washing with water and soap (that may or may not contain antimicrobials) is recommended when the hands are visibly soiled. In other cases, alcohol-based antiseptics/hand disinfectants or washing with antimicrobial soap and water are recommended in many clinical situations such as before direct patient contact, prior or following glove use etc.


  • For surgical hand antisepsis or hand disinfection, alcohol-based antiseptics/hand disinfectants or washing with antimicrobial soap and water are recommended prior to glove donning. Some guidelines specifically recommend the use of products that have some persistent activity on the skin following application, such as in the case of chlorhexidine-containing soaps or alcohol hand rubs (see chapter 22).


  • Patient showering or bathing prior to surgery with either nonantimicrobial or antimicrobial soap or an alternative antimicrobial agent. The most commonly used biocide for the application is chlorhexidine (eg, in soaps or washcloth impregnated products) but also other biocides such as triclosan and chloroxylenol.


  • Presurgical, intraoperative skin preparation with alcohol-based antiseptics, which may or may not include chlorhexidine. Other widely used biocides include chlorhexidine and iodine (eg, iodophor) products, but alcohols are generally found to be more effective.

Intraoperative irrigation of tissues with an aqueous iodophor solution under restrictive situations, such as of deep or subcutaneous tissues, or in certain situations before wound closure of clean or clean-contaminated wounds.

In addition, it is clear that such products should meet the required efficacy, safety, and registration requirements (as applicable) for the countries in which they are marketed in (eg, under the FDA requirements26 or the European Union Biocidal Product Regulation53 and associated efficacy test standards) (see chapters 61, 62, and 63). These products should also be specifically used in compliance to manufacturer’s instructions and labeled claims.


ANTISEPTICS USED IN SURGERY

In this chapter, we use the definitions proposed by the FDA OTC Antimicrobial Panel II54 and finalized in 2017 for the use classification of health care antiseptics.26 These are considered drug products that are generally intended for use by health care professionals in a hospital setting or other health care situations outside the hospital. They can include washes that are designed to be applied with water (eg, health care personnel hand washes and surgical hand scrubs) or rubs (or leave-on products) that are applied
and not rinsed off after use (eg, health care personnel hand rubs, surgical hand rubs, and patient antiseptic skin preparations). Overall these include



  • Health care personnel hand washes or hand rubs: antiseptic-containing preparation designed for frequent use; they reduce the number of transient microorganisms on intact skin to an initial baseline level after adequate applications (eg, with hand washes by washing, rinsing, and drying); they are considered broad-spectrum, fast acting, and, if possible, persistent. Note that persistence refers prolonged activity of the applied product that assures antimicrobial activity during the interval between washings and is considered an important for a safe and effective health care personnel hand wash (as well as other products in the following text).


  • Surgical hand scrubs or rubs: an antiseptic-containing preparation that significantly reduces the number of microorganisms on intact skin; it is broad-spectrum, fast acting, and persistent.

Patient antiseptic skin preparations (ie, patient preoperative and preinjection skin preparations): fast-acting, broad-spectrum, and persistent antiseptic containing preparation that significantly reduces the number of microorganisms on intact skin. Examples include products used for patient preoperative or preinjection skin preparations.

The antimicrobial ingredients of such preparations were initially placed by the FDA54 in three categories: category I, generally recognized as safe and effective and not misbranded; category II, not generally recognized as safe and effective or misbranded; and category III, available data insufficient to classify as safe and effective, and further testing is required. These have now been replaced with products defined as being under monograph conditions (ie, previously considered category I) and nonmonograph conditions (referring to the original categories II and III products). First aid antiseptics are considered separately under a separate monograph.55 These regulatory requirements led to many restrictions on the range of biocides that may be used in these products as well as the continuing requirements for new drug applications for the specific use of certain types of biocides (as discussed earlier). Equally in Europe, the range of antimicrobials are restricted based on the environmental safety, antimicrobial effectiveness, and toxicity requirements defined for these types of products.53,56 For detailed information on the chemical, antimicrobial, and toxic properties of each active component, the reader is referred to the respective chapter of this book.


Alcohols

Alcohols are effective antiseptic agents with a broad spectrum of activity (see chapter 19). Isopropyl alcohol is known to be effective against bacteria, mycobacteria, fungi, and large or lipid-containing viruses (eg, human immunodeficiency virus [HIV] and hepatitis B virus [HBV]) but is significantly less effective against hydrophilic viruses (eg, rotavirus or parvoviruses) in the use of dilutions of 60% to 95%. Ethyl alcohol has a similar spectrum of activity, with similar restrictions on efficacy against hydrophilic viruses (see chapters 19 and 42).57 Alcohols are now well established as offering the most rapid and reliable reduction of microbial counts on skin for personnel hand rubbing, surgical scrub, and patient preoperative skin preparations (see chapters 16, 20, 21, 42, and 49). One of the concerns regarding the use of alcohol preparations is the flammability and potential for burn injury in the operating room,58 although when they are used appropriately, there is little risk of such injury.16,17,59

The benefit of alcohol preparations containing emollient and refatting additives that retard evaporation and in combination with other antimicrobial chemicals have been reported in multiple studies (see chapter 42).60 Other opportunities include the optimized concentration of alcohols in these formulations and application times.61 The call for more effective and rapidly acting antiseptics has increased the interest of health care workers in alcohol antiseptics and has stimulated the industry to offer such preparations with and without the addition of an additional antimicrobial chemical, such as chlorhexidine gluconate.


Chlorhexidine

Chlorhexidine gluconate replaced hexachlorophene as an active ingredient for surgical antiseptics in the 1970s. In wash formulations that can typically range from 0.5% to 4% detergent preparation, it has a broad antimicrobial spectrum, but it is less active against gram-negative than gram-positive bacteria, it is not active against mycobacteria (see chapter 22), it is moderately active against fungi, and it is generally active against enveloped viruses (but no nonenveloped viruses). Although not as rapidly acting as alcohol, chlorhexidine gluconate is well accepted as a surgical antiseptic, with residual activity caused by its strong affinity for the skin and little interference by blood. In addition to wash products, it is also marketed at lower concentrations (eg, 0.1%-0.5%) in alcohols, thereby combining the rapid effect of alcohol with the residual effect of chlorhexidine as well as in impregnated dressing (eg, used for application to the skin prior to and during the insertion of vascular devices through the skin). Chlorhexidine is considered relatively safe but has been associated with isolated episodes of hypersensitivity, including anaphylactic shock (see chapter 22).62,63


Iodine

Tincture of iodine has been used in surgery since its introduction by Grossich in Fiume in 1908 for preoperative skin preparation (see chapter 16).64 The old-fashioned tincture (7% iodine and 5% potassium iodide in 85% ethyl alcohol)
was much too strong and caused considerable skin burns.65 Examples of more modern iodine tinctures include solutions or tinctures containing 2 ± 0.2 g iodine and 2.1 to 2.6 g sodium iodide in 100 mL purified water or in 44% to 50% ethyl alcohol. Both preparations are considered reasonably safe and rapidly acting with a broad antimicrobial spectrum, but the solution has overall been found to be inferior to the tincture in clinical use.65 One percent or 2% iodine with an equal amount of potassium iodide in 70% ethyl alcohol was considered as the most effective in reducing skin flora.65 Due to previous risks of skin burns, these products were often recommended in the past to be removed from the operative site immediately on drying with 70% alcohol to prevent skin burns. This also applied to the use of tincture of iodine in other applications such as before punctures to obtain blood, body fluids, or tissue specimens. The problem of local toxicity has limited the use of tincture of iodine or aqueous iodine in recent years, mainly because of the arrival of alternative iodophor preparations. Iodophors are complexes of iodine with carriers such as the nonsurfactant compound polyvinylpyrrolidone (povidone or PVP) or the surfactant compound poloxamer that slowly release free iodine and thereby reduce staining and local toxicity while retaining the broad antimicrobial activity of iodine (see chapter 16). An “iodine flux” between the deeper layers of the skin and the skin surface has been claimed in the past to allow several hours of residual bactericidal activity after the initial scrub, but these effects are not consider as effective as in chlorhexidine applications.16,17

Initially, iodophors were used widely on skin, mucosa, wounds, burns, and even in body cavities, and an elevation of blood iodine levels was noted.54 Although safety and efficacy reports in the literature do vary, overall the use of iodophors in these applications are considered to have a favorable risk/benefit profile and including in acute and chronic wound treatments.66 Iodophors, most commonly povidone- or poloxamer-iodine, are used in concentrations of 0.75% to 2.0% available iodine (0.75-2 mg free iodine/L). Their activity is relatively slow, and the presence of organic materials can neutralize the free iodine (see chapter 16). Studies following the surprising finding of contamination of povidone-iodine with Pseudomonas cepacia showed that the ratio of free to bound iodine increases with dilution.67,68 Other reports suggested that P cepacia was protected in these formulations in a biofilm, likely to be sourced during the manufacturing of the product.69 Example of a low-iodine hand soap (eg, 0.05% complexed iodine) have been patented and developed and shown to be effective as personnel hand washing products, but these has not seen widespread use in clinical practice.70


Phenol Derivatives

Substituted phenols were discussed extensively by the FDA OTC Antimicrobial Panels (FDA71) and are widely used an antiseptic antimicrobials.46,51,54,71 For health care use (including patient skin preparation, in health care personal hand washes/hand rubs, and surgical preparations), these have predominantly included triclosan, para-chloro-meta-xylenol (chloroxylenol or PCMX), and in the past hexachlorophene (see chapter 42).51 Hexachlorophene at 0.1% to 3% in various formulations was widely used as an antiseptic from the 1950s up to the early 1970s, when reports of toxicity eventually led to the restrictive use of this biocide under prescription.17,72 Similar to other bisphenols, like triclosan, it had good bactericidal activity against gram-positive bacteria (particular those associated with the skin microbiome) but less activity against gram-negative bacteria and fungi (which could be improved by formulation effects such as in combination with chelating agents). This led to an increased interest in alternative biocides such as triclosan, another bisphenol used in concentrations of 0.5% to 4%. Triclosan became one of the widely used antimicrobials in both consumer and health care applications, due to its spectrum of antimicrobial activity, persistent activity on the skin, and was considered relatively nontoxic. The widespread use of triclosan led to concerns over its benefit over the use of nonantimicrobial soaps (particularly in the consumer area) and more recently the banning or restrictive use of triclosan in antiseptic applications, such as by the FDA in 2016.26,51 These included risk-benefits discussion on the benefits of the broad use of antimicrobial in the general public, increased reports of toxic reactions including hormonal effects, environmental concerns due to the persistence of the biocide and risks to aquatic life, and, finally, reports on the development of increased resistance in bacteria and cross-resistance to antibiotics.51 Although these reports continue to be the subject of debate,73,74 the use of triclosan in both consumer and health care antiseptic applications has significantly reduced and have more focused on particular applications such as the use in antimicrobial sutures that have shown clinical benefit.15,38,75

The decreased used of triclosan for surgical applications has been in parallel with an increased (or renewed) interest in the use of chloroxylenol, a halophenol.51 Similar to other antiseptic phenolics, chloroxylenol (in the 0.5% to 4% concentration range) is very dependent on formulation effects to optimize antimicrobial activity, intrinsically having greater activity against gram-positive bacteria than gram-negative bacteria (such as Pseudomonas species) or fungi.17,51 It can also demonstrate persistent activity on the skin, a particular benefit on surgical antiseptic applications. Studies on the potential or resistance or biocide tolerance development with chloroxylenol do not appear to show the same risks as with triclosan.74,76 At this time, the FDA has delayed final rulemaking on the safety and efficacy of chloroxylenol in consumer and health care antiseptic use.26,51

A further phenol derivative that is widely used as an antiseptic is salicylic acid, in particular for the treatment of acne due to being an exfoliant and demonstrating
bactericidal/fungicidal activity. Typical concentrations used in these applications range from 0.5% to 6%, in skin washes and as ointments/skin paints.51 Other applications include their use for the topical treatment of warts and psoriasis, but they are not generally used for surgical applications.

In general, it can be important to understand the length of surgical operation when deciding on the agents for skin preparation. Some studies have reported a direct relationship between the length of operation and risk for infection.77,78 Alcohol has the most rapid onset but is limited as a single agent by its lack of residual activity but can be combined with other antimicrobials (such as chlorhexidine as described earlier). Iodine/iodophors have minimal residual activity, and some residual activity has been reported with triclosan and chloroxylenol. The excellent residual effect of chlorhexidine may be advantageous in prolonged procedures.15,17,38,51


PERSONNEL HAND WASHING WITH ANTISEPTIC PREPARATIONS

For more than 140 years, it has been known that infectious agents can be carried on hands.79 Whether acquired from corpses, patients, unclean dressings, or contaminated instruments and surfaces, they can survive as transient flora on the skin for some time, and some may become part of the “nontransient” flora.24,35,36 Hand washing has been accepted for many decades as the most effective way to interrupt the chain of transmission of infection from one person to another. The guidelines for the hand washing and hand antisepsis have evolved over the years since the publication of widely used evidence-based guidelines such as the 1985 CDC Guidelines for Handwashing and Hospital Environment Control.80 These include changes in the recommendations in the types and methods of hand antisepsis.17,52 It is practical to consider that the use of soap (antimicrobial or nonantimicrobial) and water is preferred when the hands are visible soiled (such as with blood or other body fluids), but for routine use that convenient use of antimicrobial (usually alcohol-based) hand rubs (that are often preferred) or antimicrobial soap and water can be used. The guidelines specify situations when the use of antiseptic hand rubs or hand washes should be used, to include before and after direct contact with a patient, prior to donning gloves before specific patient procedures (such as catheter insertion), and on contacting patient fluids or inanimate surfaces in close vicinity to a patient (even if not visibly soiled). The methods of handling are equally important to observe. Although deferring to manufacturer’s instructions, the guidelines recommend steps in the use of hand rubs and hand washes, such as prewetting the hands before applying soap, washing for at least 15 seconds, followed by rinsing and drying.17,52 In many clinical situations, washing with plain soap has been recommended for some time unless otherwise indicated.80 Unfortunately, such guidelines were often interpreted to mean that antiseptic hand wash agents were to be replaced in all hospital areas with nonmedicated soap. Routine hand washing practices in hospitals already were often less than optimal in frequency, length and technique of washing, and quantity of soap used.81,82,83,84,85,86 Thus, the removal of antimicrobial soaps with residual activity may have had a negative effect on infection control in some institutions. Several studies demonstrated that hand washing with antiseptic soaps can reduce HAIs.70,87,88,89,90 Therefore, the guidelines continue to recommend the appropriate use of antiseptics in higher risks situations, including in surgical wards to minimize or eliminate the transient flora acquired from infected patients and reduce the resident flora, which may include gram-positive and gram-negative bacteria.17,52 Hand washing frequency and technique are dependent on many factors such as the motivation of personnel, the selection of an acceptable hand washing agent, and the availability of either sinks for hand washing or dispensers for waterless preparations.17,52,90 Alcohol-based hand rinses are highly efficacious, and such products are recommended as a health care personnel hand wash, particularly when a sink and running water are inaccessible.17,52 Senior clinicians and nurses play important roles both as decision makers and as role models for their associates.

Only gold members can continue reading. Log In or Register to continue

May 9, 2021 | Posted by in MICROBIOLOGY | Comments Off on Surgical Antisepsis
Premium Wordpress Themes by UFO Themes
%d bloggers like this: